Massachusetts-based tech company Revvity has launched a new tool to remove a data entry chore from clinical laboratories. | ...

Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...

Alpha-9 Oncology has raised a $175 million series C round to bankroll its clinical-stage radiopharmaceutical drugs, although ...

Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. | Alto Neuroscience hit a bum note ...

Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see ...

Last week, the outgoing leader of the FDA’s devices center, long-time chief Jeff Shuren, M.D., endorsed acting head Michelle ...

GSK is pumping £50 million (about $65 million) into a five-year collaboration with the University of Cambridge and Cambridge ...